Calgary mountain bikers seek to save park area
A group of mountain bike enthusiasts were out riding on Medicine Hill this week in an attempt to preserve the special area for other cyclists.
'A lot of us are concerned because the area has a deep history of mountain biking,' said the organizer for the mountain bike rally Joe Obad.
'It would be super sad to lose as a biking area.'
The City of Calgary is in Phase 1 of its engagement process for the Medicine Hill/Paskapoo Slopes Regional Park Master Plan.
According to the project's website, it will provide an opportunity to protect land with cultural, archaeological and ecological significance, while creating a regional park that shapes a landscape of connection and education for all who visit.
Calgary mountain bikers seek to save park area
The city also points to the area's significance for local Indigenous nations.
Obad and other mountain bikers worry since the pillars for the redevelopment project include 'nature, culture, education and together.'
'Recreation isn't included as one of the pillars of values for the area,' said Obad.
'We want to make sure that mountain biking continues to take place at Medicine Hill.'
Calgary mountain bikers seek to save park area
The next public engagement date is set for July 19 at Medicine Hill Regional Park, near Cougar Ridge Pond.
Phase 2 public engagement which will gather feedback on the early concept designs beginning in the fall of 2025.
The city anticipates its master plan to be complete in 2026.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
26 minutes ago
- CTV News
Fundraiser hosted by University of Windsor students looks to raise as much money as possible in one hour
Moving Mountains fundraising efforts hosted by University of Windsor's Medlife chapter aims to raise money for low-income communities in Latin America and Africa. (courtesy Mohammed Abdulaziz) Windsor, Ont. — A fundraiser hosted by University of Windsor students from the school's Medlife chapter hopes to show how much heart the city really has. Due to COVID-19, the organization which partners with low-income communities in Latin America and Africa to improve access to medicine, education and community development initiatives is unable to be on the ground in these areas and is instead holding its Moving Mountains Fundraiser. 'Due to the COVID-19 Pandemic, we have been unable to go on a service learning trip, and our organization has been working on ways to support underprivileged communities in South America,' University of Windsor's Medlife chapter co-presidents Mohammed Abdulaziz and Saya Albonaimi said in an email to CTV Windsor. There are more than 264 Medlife chapters across North America, in addition to service trips, the organization has a Medlife Project Fund which aims to raise money to send to impoverished communities around the world. 'Our current initiative is the Moving Mountains Fundraiser, where over 100 plus Universities across North America have participated in raising money for food, water, and supplies to communities that simply do not have the privileges we are so blessed to have,' Abdulaziz said. The fundraiser will be held on July 17, from 7 p.m. to 8 p.m. where UWindsor students will be contacting people to try and raise as much money by contacting as many people as they can to raise as much money as possible in an hour. So far, the best performing University in North America is Queens who raised almost $9,500 in one hour to send to vulnerable families impacted by COVID-19 raising $9,500 in one hour. 'Our Windsor chapter is looking to show that our smaller community has more heart and spirit than our size suggests, and we are going to put our best foot forward for our fundraiser on July 17, 7 p.m. – 8 p.m., having a friendly competition with UOttawa and McMaster University to see who can raise the most money,' Abdulaziz said.
CBC
29 minutes ago
- CBC
Another person dead in London, Ont., legionnaires' outbreak
Another person has died and 20 more are sick from legionnaires' disease in London, Ont., pubic health officials warn. That brings the outbreak to a total of two people dead and 64 sick since it was declared by the Middlesex-London Health Unit less than a week ago, on July 8. The patients have ranged in age from 23- to 93-years old, but health officials still don't have an exact source of the deadly bacteria, or whether it is linked to an outbreak that killed two people last year. On Monday, officials released a map to indicate the general area most impacted by the outbreak, though it takes in a large chunk of the city. "Despite this cluster of cases, the overall risk to the broader community remains low, particularly for individuals who are not at higher risk," officials said. "Homes and businesses in the area remain open and are expected to follow all recommended health and maintenance protocols. Residents are not discouraged from continuing their daily routines in this area." The blue circle of the map represents a six-kilometre radius around the average location of all home addresses of reported cases, and is a snapshot in time, health officials say. "The 6-kilometre radius may not reflect the actual distribution or movement patterns of individuals affected by the outbreak," the health unit said in an emailed statement. " Although this map shows where the greatest density of cases reside, there are confirmed Legionnaires' cases outside of this area." 1 dead, over 40 sick as legionnaires' outbreak spreads in southeast London, Ont. 5 days ago Duration 3:04 One person is dead and more than 40 people have become ill in an outbreak of legionnaires' disease in London, Ont. Legionnaires' disease is caused by legionella bacteria, naturally found in water sources such as hot tubs, cooling towers, hot water tanks, large plumbing systems or parts of air-conditioning systems. Legionella is not transmitted from person to person. If the bacteria are aerosolized or misted into the air (via wind or fans), people may inhale the bacteria and become unwell. Most people exposed to legionella don't get ill, but some may experience Pontiac fever, a mild, flu-like illness that commonly resolves itself. Individuals who are older, have lung problems or are immunocompromised are at greater risk of serious infection. Health officials defended taking so long to release a map of the area, saying it took time to gather sufficient information to get a map together and that the priority was working with property owners and operators of water-cooling systems to clean and maintain their systems as a precautionary measure. "Legionella aerosolizes and travels significant distance. The source of the Legionella spread has not yet been found," officials said.
National Post
37 minutes ago
- National Post
Aspect Biosystems Presents New Preclinical Data on Adrenal Bioprinted Tissue Therapeutics at ENDO 2025
Article content Preclinical data highlight the potential of Aspect's adrenal Bioprinted Tissue Therapeutics to restore adrenal function and treat primary adrenal insufficiency Article content VANCOUVER, British Columbia — Aspect Biosystems, a biotechnology company pioneering the development of Bioprinted Tissue Therapeutics (BTTs) as a new category in regenerative medicine, today announced new preclinical data at ENDO 2025, the Endocrine Society's annual meeting held in San Francisco. The company presented an oral and poster presentation highlighting that Aspect's adrenal BTTs can restore adrenal function, following natural daily hormone rhythms and maintaining long-term performance in animal models of primary adrenal insufficiency. Article content Primary adrenal insufficiency is a serious, life-threatening condition in which the adrenal glands fail to produce sufficient levels of essential hormones such as cortisol, a key regulator of the body's stress response. The current standard of care involves daily hormone replacement therapy, which does not fully replicate the body's natural circadian hormone rhythms and is associated with significant drug-related side effects. This can leave patients with a poor quality of life and at risk of ongoing health challenges, including potentially fatal adrenal crises. Aspect's adrenal BTTs were developed using the company's proprietary full-stack tissue therapeutic platform, which combines AI-powered bioprinting, computational design tools, therapeutic cells, and advanced biomaterials. Article content In preclinical studies, adrenal BTTs containing human adrenal cells were implanted into adrenalectomized mice. These BTTs produced cortisol in response to adrenocorticotropic hormone (ACTH) stimulation—which is normally secreted from the brain—and followed the animals' natural circadian fluctuations in hormone levels. When exposed to high levels of injected ACTH, these mice demonstrated rapid increases in circulating cortisol, confirming that the adrenal BTTs were functionally responsive. In contrast, control animals receiving cell-free implants showed no significant cortisol levels and did not respond to ACTH stimulation. Importantly, adrenal BTTs remained functional in vivo throughout the study period of over six months and improved animal survival. Article content 'Our research shows that Aspect's adrenal BTTs successfully replicate healthy human adrenal gland function by releasing cortisol in a pattern that follows the natural daily rhythms of hormone release and by responding appropriately to a stimulus that mimics a stress response,' said Sam Wadsworth, PhD, Chief Scientific Officer at Aspect Biosystems. 'These results demonstrate that our off-the-shelf, implantable cell therapy can work in harmony with the body's physiology and has real potential to serve as a functional cure for primary adrenal insufficiency.' Article content 'At Aspect, we're making breakthrough progress with our Bioprinted Tissue Therapeutics platform to restore complex biological functions across a range of serious endocrine and metabolic diseases,' said Tamer Mohamed, Chief Executive Officer of Aspect Biosystems. 'This latest advance in primary adrenal insufficiency, a rare and life-threatening condition with limited treatment options, showcases the potential of a bioengineered cell therapy to recreate natural hormone function and deliver a truly disease-modifying solution. This reflects our mission to develop regenerative medicines capable of achieving functional cures for patients with serious and underserved diseases.' Article content About ENDO Article content Hosted by the Endocrine Society, ENDO is the leading global meeting on endocrinology research and clinical care. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions. Learn more at Article content About Aspect Biosystems Article content Aspect Biosystems is a biotechnology company pioneering the development of Bioprinted Tissue Therapeutics (BTTs) to transform how we treat some of the most elusive diseases. Aspect's BTTs are designed to replace, repair, or supplement biological function inside the body. Aspect is creating these next-generation cell therapies by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials. Aspect is advancing a pipeline of BTTs across multiple disease areas in the endocrine and metabolic space including diabetes, obesity, rare endocrine disorders, and liver disease. Aspect's pipeline development strategy involves both proprietary programs as well as strategic partnerships, including a collaboration with Novo Nordisk focused on diabetes and obesity. For more information, please visit and follow on LinkedIn. Article content Article content Article content Article content
